Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-21-110599

Chief Business Officer gave up 1,149 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Korbel Gregory Alan Chief Business Officer 2021-08-25 Shares withheld for taxes −1,149 $3.98 $4,573 24,351 D
Loading xslF345X03/tm2126037-3_4seq1.xml…